期刊
NATURE REVIEWS NEUROLOGY
卷 10, 期 2, 页码 68-70出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrneurol.2013.268
关键词
-
In 2013, two discoveries-that alkylating agent chemotherapy prolongs survival when added to radiotherapy for patients with anaplastic oligodendroglial tumours with 1p19q codeletion, and that bevacizumab prolongs progression-free survival in patients with newly diagnosed glioblastoma-have dominated debate in neuro-oncology. These findings could help to define new standards of care in malignant glioma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据